EUVIMEDEUVIMED entdecken
Crossref

Rabeprazole exhibits broad-spectrum fusion inhibition against Nipah pseudovirus and authentic HCoV-OC43 and RSV

Yunyue Shen, Boxuan Wang, Jie Li, Ze Liang, Lili Liu, Guang Yang, Lei Yan

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Yunyue Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, Shang…. Hauptthemen laut MEDLINE: Rabeprazole, Antiviral Agents, Coronavirus OC43, Human, Respiratory Syncytial Viruses. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China Stem Cell and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rabeprazole was previously defined as a small-molecule fusion inhibitor that binds the conserved hydrophobic HR1 groove of the SARS-CoV-2 spike and blocks six-helix bundle assembly. Here, we expand its antiviral spectrum and demonstrate potent activity against Nipah virus pseudotype, HCoV-229E, and RSV. Using SPR, pseudovirus neutralization, docking, and 100-ns MD simulations, we validated binding of Rabeprazole to the HR1 domains of NiV F glycoprotein and HCoV-229E spike, with a conserved fusion-inhibitory mechanism. Systematic structure-activity relationship (SAR) profiling among clinically approved PPIs revealed that Ilaprazole and Lansoprazole exhibited stronger anti-NiV potency than Rabeprazole, while Rabeprazole sulfide showed enhanced antiviral activity relative to the parent compound. Rabeprazole also inhibited live RSV and HCoV-229E infection in a dose-dependent manner. Collectively, these findings establish the HR1 groove as a druggable pan-viral target and validate benzimidazole-based PPIs as a versatile scaffold for developing orally available, broad-spectrum antivirals against phylogenetically distinct enveloped viruses that rely on class I fusion machinery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RabeprazoleAntiviral AgentsCoronavirus OC43, HumanRespiratory Syncytial VirusesCoronavirus 229E, HumanHumansStructure-Activity RelationshipDose-Response Relationship, DrugMolecular StructureAnimalsMolecular Docking SimulationMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Broad‑spectrum antiviralHR1 domainNipah virusProton‑pump inhibitors (PPIs)RabeprazoleViral fusion inhibitor

Substanzen

RabeprazoleAntiviral Agents

Autor:innen und Institutionen

  • Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.
  • School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China; International Research Center of Synthetic Biology, Nanjing Normal University, Nanjing 210023, China; State Key La…
  • Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China; School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China; Internati…
  • Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China; Department of Biomedical Engineering, College of Basic Medical Sciences, Second Military Medical University, Shang…

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Shen, Y., Wang, B., Li, J., Liang, Z., Liu, L., Yang, G., & Yan, L. (2026). Rabeprazole exhibits broad-spectrum fusion inhibition against Nipah pseudovirus and authentic HCoV-OC43 and RSV. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110387

Vancouver

Shen Y, Wang B, Li J, Liang Z, Liu L, Yang G, et al. Rabeprazole exhibits broad-spectrum fusion inhibition against Nipah pseudovirus and authentic HCoV-OC43 and RSV. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110387

BibTeX
@article{Shen2026,
  author = {Shen, Yunyue and Wang, Boxuan and Li, Jie and Liang, Ze and Liu, Lili and Yang, Guang and Yan, Lei},
  title = {Rabeprazole exhibits broad-spectrum fusion inhibition against Nipah pseudovirus and authentic HCoV-OC43 and RSV},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110387}
}
Kostenlos starten →